Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals

Journal of the American Medical Association

Volumn 286, Issue 4, 2001, Pages 421-426

  Gerstein, Hertzel C ^a   Mann, Johannes F E ^b   Yi, Qilong ^a   Zinman, Bernard ^c   Dinneen, Sean F ^d   Hoogwerf, Byron ^e   Hallé, Jean Pierre ^f   Young, James ^e   Rashkow, Andrew ^g   Joyce, Carol ^h   Nawaz, Shah ⁱ   Yusuf, Salim ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Klinikum Schwabing   (Germany)

^c MOUNT SINAI HOSPITAL   (Canada)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g GRIFFIN HOSPITAL   (United States)

^h MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

ⁱ SUDBURY REGIONAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART INFARCTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MORTALITY; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0035948631     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.4.421     Document Type: Article

References (47)

1. Heart disease and diabetes
2. Diabetes and cardiovascular disease: The Framingham study
3. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
4. Factors predictive of long-term coronary heart disease mortality among 10059 male Israeli civil servants and municipal employees
5. Cardiovascular risk factors as predictors of mortality in type II diabetic patients
6. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
7. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality: The San Antonio Heart Study
8. The association of glycemia and cause-specific mortality in a diabetic population
9. Long-term glycemic control relates to mortality in type II diabetes
10. NIDDM and its metabolic control predict coronary heart disease in elderly subjects
11. Prevalence and determinants of MA in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study
12. Microalbuminuria as predictor of vascular disease in nondiabetic subjects
13. Microalbuminuria is associated with insulin resistance in nondiabetic subjects
14. Microalbuminuria in nondiabetic adults
15. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus
16. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus
17. Microalbuminuria as predictor of increased mortality in elderly people
18. Urinary albumin excretion: A predictor of risk of cardiovascular disease
19. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects
20. Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction
21. L'escrezione urinaria di albumina aumenta durante infarto miocardico acuto soprattutto nei pazienti che sviluppano insufficienza cardiaca
22. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality
23. Enhanced urinary excretion of albumin in congestive heart failure: Effect of ACE-inhibition
24. The HOPE (Heart Outcomes Prevention Evaluations) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events
25. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes: The MICRO-HOPE study
26. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus
27. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
28. Proteinuria: What value is the dipstick?
29. 1998 Clinical practice guidelines for the management of diabetes in Canada
30. Urinary albumin excretion: An independent predictor of ischemic heart disease
31. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: A 15-year follow-up from the time of diagnosis
32. Microalbuminuria precedes the development of NIDDM
33. Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study
34. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension
35. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension
36. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: Results from the hypertension detection and follow-up program
37. Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study
38. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM
39. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
40. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus
41. A diagnostic programme for quantitative analysis of proteinuria
42. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy
43. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio
44. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects
45. Urinary albumin excretion in a population based cohort
46. Adjustment for regression dilution in epidemiological regression analyses
47. Blood pressure, stroke, and coronary heart disease, I: Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias